I N T H E K N OW
UNDER THE
MICROSCOPE
P
ennsylvania’s largest ever
medical cannabis study f inds
99% of patients in the state
achieve a better quality of life with
improved access.
Almost all Pennsylvanian medical
cannabis patients who took part in a
recent explorative survey were able to
reduce pain, experience better sleep,
suffer less anxiety and less f requent
seizures according to the results.
A white paper published on the f irst
of its kind study in the state, almost
four years after medical cannabis
was legalized there, also found
the majority of patients gained an
increase in appetite and experienced
22
fewer withdrawal symptoms (in
cases of opioid use disorder).
More than half of the 2,000
respondents said they did not
experience any negative side effects
of using medical cannabis.
Aff inity Biopartners, AI Health
Outcomes and Compassionate
Certif ications collaborated on this
study, which will provide insight into
the purpose of and explore just how
effective the Keystone State’s medical
cannabis program is.
This data may present inspiration to
law makers in other states where
medical cannabis has not yet been
made as welcome.